1 Benchimol EI, Fortinsky KJ, Gozdyra P, den Heuvel MV, Limbergen JV, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17:423–9.
2 Muise AM, Snapper SB, Kugathasan S. The age of gene discovery in very early onset inflammatory bowel disease. Gastroenterology. 2012;143:285–8.
3 Heyman MB, Kirschner BS, Gold BD, Ferry G, Baldassano R, Cohen SA, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. The Journal of pediatrics. 2005; 146:35–40.
4 Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147:990–1007.e3.
5 Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, et al. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr. 2012; 55:340–61.
6 Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361: 2033–45.
7 Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–21.
8 Zhu L, Shi TT, Zhong CD, Wang YD, Chang M, Liu XL. IL-10 and IL-10 receptor mutations in very early onset inflammatory bowel disease. Gastroenterol Res. 2017;10(2):65-9.
9 Zheng CF, Huang Y, Hu WH, Shi JR, Ye ZQ, Qian XW, et al. Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study. Inflamm Bowel Dis. 2019;25(4):756-66.
10 Mao H, Yang W, Lee PP, Ho MH-K, Yang J, Zeng S, et al. Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn’s disease. Genes Immun. 2012;13:437–42.
11 Yanagi T, Mizuochi T, Takaki Y, Eda K, Mitsuyama K, Ishimura M, et al. Novel exonic mutation inducing aberrant splicing in the IL10RA gene and resulting in infantile-onset inflammatory bowel disease: a case report. BMC Gastroenterol. 2016;16:10.
12 Oh SH, Baek J, Liany H, Foo JN, Kim KM, Yang SC-O, et al. A synonymous variant in IL10RA affects RNA splicing in pediatric patients with refractory inflammatory bowel disease. J Crohns Colitis. 2016;10:1366–71.
13 Shim JO, Seo JK. Very early-onset inflammatory bowel disease (IBD) in infancy is a different disease entity from adult-onset IBD; one form of interleukin-10 receptor mutations. J Hum Genet. 2014;59: 337-41.
14 Shim JO, Hwang S, Yang HR, Moon JS, Chang JY, Ko JS, et al. Interleukin-10 receptor mutations in children with neonatal-onset Crohn’s disease and intractable ulcerating enterocolitis. Eur J Gastroenterol Hepatol. 2013; 25: 1235-40.
15 Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, Boztug K, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012;143(2):347-55.
16 Pigneur B, Escher J, Elawad M, Lima R, Buderus S, Kierkus J, et al. Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the Genius Working Group. Inflamm Bowel Dis. 2013;19(13):2820-28.
17 El Mouzan M, Al-Mofarreh M, Assiri A, Hamid Y, Saeed A. Consanguinity and inflammatory
bowel diseases: is there a relation? J Pediatr Gastroenterol Nutr. 2013;56:182–5.
18 Beser OF, Conde CD, Serwas NK, Cokugras FC, Kutlu T, Boztug K, et al. Clinical features of interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2015;60:332–8.
19 Engelhardt KR, Shah N, Faizura-Yeop I, Uygun Kocacik DF, Frede N, Muise AM, et al. Clinical outcome in IL-10 and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013;131:825–30.
20 Glocker EO, Kotlarz D, Klein C, Shah N, Grimbacher B. IL-10 and IL-10 receptor defects in humans. Ann N Y Acad Sci. 2011;1246:102–7.
21 Moran CJ, Walters TD, Guo CH, Kugathasan S, Klein C, Turner D, et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm. Bowel Dis. 2013;19:115–23.
22 Oliva-Hemker M, Hutfless S, Al Kazzi ES, Lerer T, Mack D, LeLeiko N, et al. Clinical presentation and five-year therapeutic management of very early-onset inflammatory bowel disease in a large North American cohort. J Pediatr. 2015;167: 527–32.
23 Veenbergen S, van Leeuwen MA, Driessen GJ, Kersseboom R, de Ruiter LF, C Raatgeep RH, et al. Development and function of immune cells in an adolescent patient with a deficiency in the Interleukin-10 receptor. J Pediatr Gastroenterol Nutr. 2017;65:e5–e15.
24 Miller TL, Lee D, Giefer M, Wahbeh G, Suskind DL. Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report. Dig Dis Sci. 2017;62(8):2196-200.
25 Huang ZH, Peng KY, Li XQ, Zhao RQ, You JY, Cheng XY, et al. Mutations in interleukin-10 receptor and clinical phenotypes in patients with very early onset inflammatory bowel disease: a Chinese VEO-IBD collaboration group survey. Inflamm Bowel Dis. 2017;23(4): 578-90.
26 Fumery M, Pariente B, Sarter H, Savoye G, Spyckerelle C, Djeddi D, et al. Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study. Dig Liver Dis. 2019;51(4):496-502.